SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kappac Pharma informs about board meeting

28 Jan 2017 Evaluate

Kappac Pharma has informed that the meeting of the Board of Directors of the Company will be held on February 11, 2017, to consider the unaudited financial results of the company for quarter and year ending December 31, 2016. As per ‘Code of Internal Procedure and Conduct for Prevention of Insider Trading’ in Shares of the Company (Code), the trading window will remain closed from January 29, 2017 to February 13, 2017 in connection with the announcement of the unaudited financial results of the Company for quarter and year ending December 31, 2016 for Directors and other employees of the Company covered under the Code. The trading window will reopen on February 13, 2017.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1670.50
Dr. Reddys Lab 1223.85
Cipla 1231.90
Zydus Lifesciences 932.25
Lupin 2327.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×